<DOC>
	<DOC>NCT00515255</DOC>
	<brief_summary>The purpose of this study is to investigate the effect of NPL-2003 on the symptoms of Obsessive Compulsive Disorder (OCD) in an adolescent population.</brief_summary>
	<brief_title>Study of NPL-2003 in Adolescents With Obsessive Compulsive Disorder (OCD)</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<criteria>Meets DSMIV criteria for Obsessive Compulsive Disorder. CYBOCS score of greater or equal to 16 at screening. NIMH Global OC Scale score of 7 or higher at screening. Patients planning to commence cognitive behaviour therapy during the period of the study or those who have begun cognitive behaviour therapy within 8 weeks prior to enrolment. Autistic Disorder or Pervasive Developmental Disorder. Moderate or severe mental retardation. Severe renal insufficiency. Other protocoldefined Inclusion/Exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Obsessive Compulsive Disorder</keyword>
	<keyword>Neuropharm</keyword>
	<keyword>NPL-2003</keyword>
</DOC>